Directory
Felipe Vilardell Villellas

Felipe Vilardell Villellas

Degree: PhD


fvilardell.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/B-8141-2015

Publications

  • Vilardell, Felip; Pardina, Marina; Olsina, Jorge Juan; Matias-Guiu, Xavier

    Multifocal granular cell tumour of the biliary tree.

    Bmj Case Reports 11 -. .

    [doi:10.1136/bcr-2018-226352]

  • Fernandez Armenteros, Jose Manuel; Arco Huguet, Nuria; Sanmartin Novell, Veronica; Vilardell Villellas, Felip; Velasco Sanchez, Ana; Martro Catala, Elisa; Marti Laborda, Rosa Maria; Soria Gili, Xavier

    Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series

    PEDIATRIC BLOOD & CANCER 65 -. .

    [doi:10.1002/pbc.27047]

  • Cortes, C; Bielsa, S; Fernandez, JM; Vilardell, F; Gonzalez-Farre, B; Casanova, JM

    Extensive Nasal Plaque: An Unusual Presentation of IgG4-related Disease

    ACTA DERMATO-VENEREOLOGICA 98 606-607. .

    [doi:10.2340/00015555-2917]

  • Garcia-de-La-Fuente, MR; Santacana, M; Valls, J; Vilardell, F; Fernandez Armenteros, Jose Manuel; Pujol, R; Gari, E; Casanova, JM

    Cytokeratin Profile of Basal Cell Carcinomas According to the Degree of Sun Exposure and to the Anatomical Localization

    AMERICAN JOURNAL OF DERMATOPATHOLOGY 40 342-348. .

    [doi:10.1097/DAD.0000000000001042]

  • Matas-Nadal, C; Sòria X; Garcia-de-la-Fuente, MR; Huerva, V; Ortega, E; Vilardell, F; Gatius, S; Casanova, JM; Marti, RM

    Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma

    JOURNAL OF DERMATOLOGY 45 564-570. .

    [doi:10.1111/1346-8138.14248]

  • Fernandez Armenteros JM; Veà Jódar A; Matas Nadal C; Cortés Pinto C; Soria Gili X; Martí Laborda RM; Vilardell Villellas F; Casanova Seuma JM

    Severe and recurrent levamisole-induced cutaneous vasculopathy

    JOURNAL OF CUTANEOUS PATHOLOGY 45 309-311. .

    [doi:10.1111/cup.13105]

  • Kim, WH; Gomez-Izquierdo, L; Vilardell, F; Chu, KM; Soucy, G; dos Santos, LV; Monges, G; Viale, G; Brito, MJ; Osborne, S; Noe, J; Du, X

    HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study

    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 26 239-245. .

    [doi:10.1097/PAI.0000000000000423]

  • Novell, A; Morales, S; Valls J; Panades, MJ; Salud, A; Iglesias, E; Vilardell, F; Matias-Guiu, X; Llombart-Cussac, A

    Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    HISTOLOGY AND HISTOPATHOLOGY 32 909-915. .

    [doi:10.14670/HH-11-849]

  • García-de-la-Fuente MR; Santacana, M; Vilardell, F; Pujol, RM; Gari, E; Casanova, JM

    Vulvar Basal Cell Carcinoma: Four Case Reports With Immunohistochemical Study

    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY 21 457-459. .

    [doi:10.1177/1203475417712498]

  • Morales, S.; Gasol Cudos, A.; Novell Alvarez, A.; Vilardell Villellas, F.; Panades Siurana, M. J.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.

    Vitamin D as a prognostic factor in triple negative early breast cancer

    ANNALS OF ONCOLOGY 28 -. .

  • Ortiz-Brugues, A; Marti-Laborda, RM; Azon-Masoliver, A; Vilardell-Vilellas, F; Casanova-Seuma, JM

    Lymphoproliferative CD30-positive disorder in a patient with a folliculotropic mycosis fungoides

    Journal Der Deutschen Dermatologischen Gesellschaft 15 577-579. .

    [doi:10.1111/ddg.12569]

  • Huerva, V; Traveset, AE; Vilardell, F

    Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia

    Ocular Immunology And Inflammation 25 284-286. .

    [doi:10.3109/09273948.2015.1115880]

Projects

  • Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • CONTRATOS POSTDOCTORALES DE PERFECCIONAMIENTO SARA BORRELL